BeOne Medicines Ltd 10-Q for FY2023 Q2
BeOne Medicines Ltd. (ONC)
10-Q
2023-08-02
For: 2023-06-30
View Original
Added on
April 06, 2026
About this 10-Q
BeOne Medicines Ltd filed this 10-Q on August 2, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).
Headline figures
Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $595.26M
- up 74.3% from $341.57M a year earlier
- Net loss
- $381.14M
- compared with a net loss of $565.73M a year earlier
- Diluted EPS
- -$0.28
- compared with -$0.42 a year earlier